Lazard Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-4
| Closed | -$1K | – | 2319 |
|
2024
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 2205 |
|
2024
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 2125 |
|
2024
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 2127 |
|
2024
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 1956 |
|
2023
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 2186 |
|
2023
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 2215 |
|
2023
Q2 | $1K | Sell |
4
-1
| -20% | -$250 | ﹤0.01% | 2245 |
|
2023
Q1 | $2K | Hold |
5
| – | – | ﹤0.01% | 2200 |
|
2022
Q4 | $2K | Buy |
5
+1
| +25% | +$400 | ﹤0.01% | 2281 |
|
2022
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 2234 |
|
2022
Q2 | $1K | Sell |
4
-2,322
| -100% | -$581K | ﹤0.01% | 2309 |
|
2022
Q1 | $1.31M | Sell |
2,326
-5,008
| -68% | -$2.82M | ﹤0.01% | 962 |
|
2021
Q4 | $5.54M | Sell |
7,334
-1,875
| -20% | -$1.42M | 0.01% | 759 |
|
2021
Q3 | $6.87M | Sell |
9,209
-2,110
| -19% | -$1.57M | 0.01% | 689 |
|
2021
Q2 | $7.29M | Buy |
11,319
+11,077
| +4,577% | +$7.14M | 0.01% | 659 |
|
2021
Q1 | $138K | Buy |
242
+23
| +11% | +$13.1K | ﹤0.01% | 1154 |
|
2020
Q4 | $127K | Sell |
219
-341
| -61% | -$198K | ﹤0.01% | 1148 |
|
2020
Q3 | $287K | Buy |
560
+495
| +762% | +$254K | ﹤0.01% | 935 |
|
2020
Q2 | $29K | Buy |
65
+6
| +10% | +$2.68K | ﹤0.01% | 1376 |
|
2020
Q1 | $20K | Buy |
+59
| New | +$20K | ﹤0.01% | 1436 |
|
2019
Q2 | – | Sell |
-4,026
| Closed | -$1.23M | – | 1195 |
|
2019
Q1 | $1.23M | Buy |
+4,026
| New | +$1.23M | ﹤0.01% | 820 |
|